Top-News

Sirtex Medical News

Keine aktuellen Kursdaten verfügbar
WKN: 552811
ISIN: AU000000SRX1
US-Symbol: SXMDF
Typ: Aktie

Sirtex Medical News

19.01.21 - PR Newswire
Sirtex Medical announces collaboration update with OncoSec Medical
Sirtex Medical announces collaboration update with OncoSec Medical PR Newswire
19.01.21 - PR Newswire
Sirtex Medical announces collaboration update with OncoSec Medical
Sirtex Medical announces collaboration update with OncoSec Medical PR Newswire
19.01.21 - PR Newswire
OncoSec Enters into Option Agreement with Sirtex Medical to Co-Promote TAVO™
OncoSec Enters into Option Agreement with Sirtex Medical to Co-​Promote TAVO™ Sirtex to Pay $5 Million for a Non-​Exclusive Option to Co-​Promote TAVO in Patients with Checkpoint ...
05.07.17 - PR Newswire
Neue Analyse von Daten zur Erstlinientherapie mit SIR-Spheres® Y-90 Harz-Mikrosphären bei Patienten mit Lebermetastasen eines rechtsseitigen primären Kolonkarzinoms
Neue Analyse von Daten zur Erstlinientherapie mit SIR-​Spheres® Y-90 Harz-​Mikrosphären bei Patienten mit Lebermetastasen eines rechtsseitigen primären Kolonkarzinoms PR ...
03.07.17 - PR Newswire
New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
New Analysis Reveals First-​Line Treatment Data on SIR-​Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-​Sided Primary Colon Cancer PR Newswire
03.07.17 - PR Newswire
New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
New Analysis Reveals First-​Line Treatment Data on SIR-​Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-​Sided Primary Colon Cancer PR Newswire
08.06.17 - PR Newswire
Ergebnisse einer neuen asiatisch-pazifische Studie belegen: SIR-Spheres® Y-90 Harz-Mikrosphären zeigen verglichen mit Sorafenib keinen signifikanten Unterschied im Gesamtüberleben bei fortgeschrittene
Ergebnisse einer neuen asiatisch-​pazifische Studie belegen: SIR-​Spheres® Y-90 Harz-​Mikrosphären zeigen verglichen mit Sorafenib keinen signifikanten Unterschied im ...
05.06.17 - PR Newswire
SIR-Spheres® Y-90 Resin Microspheres Showed No Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse Events, New Asia-Pacific St
SIR-​Spheres® Y-90 Resin Microspheres Showed No Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse ...
05.06.17 - PR Newswire
SIR-Spheres® Y-90 Resin Microspheres Showed No Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse Events, New Asia-Pacific St
SIR-​Spheres® Y-90 Resin Microspheres Showed No Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse ...
24.05.17 - PR Newswire
REsect-Studie: Patienten mit metastasiertem Kolorektalkarzinom, die in der Erstlinientherapie mit SIR-Spheres® Y-90 Harz-Mikrosphären behandelt wurden, kommen mit höherer Wahrscheinlichkeit für potenz
REsect-​Studie: Patienten mit metastasiertem Kolorektalkarzinom, die in der Erstlinientherapie mit SIR-​Spheres® Y-90 Harz-​Mikrosphären behandelt wurden, kommen mit höherer ...
24.05.17 - PR Newswire
Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows
Metastatic Colorectal Cancer Patients Treated First-​line With SIR-​Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, ...
24.05.17 - PR Newswire
Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows
Metastatic Colorectal Cancer Patients Treated First-​line With SIR-​Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, ...
05.05.17 - PR Newswire
Erhebliche Verbesserung der Überlebensqualität bei primärem Leberkrebs durch SIR-Spheres® Y-90 Harz-Mikrosphären
Erhebliche Verbesserung der Überlebensqualität bei primärem Leberkrebs durch SIR-​Spheres® Y-90 Harz-​Mikrosphären PR Newswire
24.04.17 - PR Newswire
SIR-Spheres® Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
SIR-​Spheres® Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows PR Newswire
24.04.17 - PR Newswire
SIR-Spheres® Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
SIR-​Spheres® Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows PR Newswire
11.10.16 - PR Newswire
Selektive interne Radiotherapie (SIRT) mit Y-90 Mikrosphären sind laut neuen Leitlinien der European Society of Medical Oncology (ESMO) für biliäre Krebserkrankungen eine Option für die Behandlung des
Selektive interne Radiotherapie (SIRT) mit Y-90 Mikrosphären sind laut neuen Leitlinien der European Society of Medical Oncology (ESMO) für biliäre Krebserkrankungen eine ...
11.10.16 - PR Newswire
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of In
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-...
11.10.16 - PR Newswire
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of In
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-...
01.07.16 - PR Newswire
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres® Y-90 resin microspheres, New SIRFLOX Analysis Shows
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-​Spheres® Y-90 resin microspheres, New SIRFLOX Analysis Shows ...
01.07.16 - PR Newswire
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres® Y-90 resin microspheres, New SIRFLOX Analysis Shows
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-​Spheres® Y-90 resin microspheres, New SIRFLOX Analysis Shows ...

Newssuche

Videos

newspaper
08:40 Uhr +5,90%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »